Patent 9764066 was granted and assigned to Mati Therapeutics on September, 2017 by the United States Patent and Trademark Office.
Lacrimal implants, methods of making lacrimal implants, and methods of treating ocular, respiration or other diseases or disorders using lacrimal implants are disclosed.